Articles, App Notes, Case Studies, & White Papers
-
Overcome The Supply Chain Complexities Of Vaccine Development
11/18/2022
Explore the industry impact of rapidly evolving vaccinology, the power of next-gen science and technology, and how finding the right supply chain partner has never been more essential.
-
Overcoming The Challenges Of Fragmented Supply Chains
1/27/2025
As trials grow more complex, managing clinical supplies is increasingly challenging. In this webinar, experts discussed GxP inventory management and integrated solutions to overcome these hurdles.
-
How Direct-To-Patient Models Can Provide Clinical Supply Chains With An End-To-End Solution
9/20/2021
Analyze the benefits and challenges of implementing direct-to-patient services in the clinical supply chain to help meet patient requirements, improve supply chain efficiency, and accelerate speed to market.
-
Choosing RTSM? Evaluate The Team Running It, Not Just The Software
2/25/2026
High-performing RTSM requires more than just code. Discover why team continuity and clinical expertise are the most overlooked factors in reducing trial risk and ensuring regulatory compliance.
-
IRT: A New Approach To Meeting The Needs Of Early Phase Trials
8/14/2025
As early phase clinical trials become more sophisticated, sponsors are now leveraging flexible IRT solutions to replace error-prone manual processes and gain greater control and efficiency.
-
End-To-End Inventory Control Supports Biotech's Expanding Portfolio
2/19/2026
Many organizations struggle with siloed operations, but this modern GxP inventory solution solves these challenges by providing a centralized, cloud-based platform for end-to-end visibility.
-
Specializing In Small And Early-Stage Partners, Not Just Small Batches
8/16/2023
Many small and/or early-stage companies are not aware of the need, or the possibility, of finding a CDMO that specializes in meeting their specific requirements.
-
RTSM And Clinical Drug Dispensation
7/16/2024
A pharma company used Signant Health's RTSM solution in a Phase 2 schizophrenia trial to ensure drug availability, maintain study balance, prevent duplicate allocations, and manage returns and destruction of unused drugs.
-
The Patient-Centric Clinical Supply Chain For Cell And Gene Therapies
8/1/2022
This article explores how delivering cell and gene therapies to patients requires new levels of agility, flexibility and innovation in the logistical management of supply.
-
Key Considerations For Packaging Solutions For Cell And Gene Therapies
Thinking of packaging and delivery factors early and often will minimize risks to the safety and efficacy of your cell and gene therapy drug product from the bench to the patient.